Selecta Biosciences
Research - Watertown, Massachusetts, United States
Selecta Biosciences Employees
Selecta Biosciences Senior Management
Selecta Biosciences Details
Selecta Biosciences Inc. (NASDAQ: SELB) is a clinical stage biotechnology company leveraging its ImmTOR platform to develop tolerogenic therapies that selectively mitigate unwanted immune responses. With a proven ability to induce tolerance to highly immunogenic proteins, ImmTOR has the potential to amplify the efficacy of biologic therapies, including redosing of life-saving gene therapies, as well as restore the body's natural self-tolerance in autoimmune diseases. Selecta has several proprietary and partnered programs in its pipeline focused on enzyme therapies, gene therapies, and autoimmune diseases.
Selecta Biosciences Technologies
Email Providers
Mimecast
CMS
WordPress.org
Support and Feedback
Zendesk
Hosting
Google Cloud Hosting
Search Marketing
Adobe Marketing Cloud